Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis.

ABSTRACT:

Objective

Antibody-drugs conjugates (ADCs) are novel drugs with highly targeted and tumor-killing abilities and developing rapidly. This study aimed to evaluate drug discovery and clinical trials of and explore the hotspots and frontiers from 2012 to 2022 using bibliometric methods.

Methods

Publications on ADCs were retrieved between 2012 and 2022 from Web of Science (WoS) and analyzed with CiteSpace 6.1.R2 software for the time, region, journals, institutions, etc. Clinical trials were downloaded from clinical trial.org and visualized with Excel software.

Results

A total of 696 publications were obtained and 187 drug trials were retrieved. Since 2012, research on ADCs has increased year by year. Since 2020, ADC-related research has increased dramatically, with the nu

SUBMITTER: Yao P 

PROVIDER: S-EPMC9850101 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature